In addition to those polymorphisms in the PNPLA3 gene, the polymorphisms in SAMM50 and PARVB were also observed to be associated with the occurrence and progression of NAFLD. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.